# OnCo record paper-checkmate-816-nejm-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-816-nejm-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-816-nejm-2022" ;
  schema:name "CheckMate 816: three cycles of nivolumab plus chemotherapy before lung cancer surgery"@en ;
  schema:description "Just three cycles of chemotherapy with the immunotherapy nivolumab before surgery wiped out all viable tumour in a quarter of patients and reduced relapse or death by about a third, without making surgery harder."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-816-nejm-2022/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2202170>, <https://clinicaltrials.gov/study/NCT02998528> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2202170> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Forde PM, Spicer J, Lu S, et al." ;
  onco:related <https://onco.cc/roadmaps/lung-cancer-evidence-roadmap/>, <https://onco.cc/key-papers/paper-heymach-aegean-perioperative-durvalumab-nejm-2023/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/lung-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:institutions <https://onco.cc/institutions/johns-hopkins/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/efs/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:people <https://onco.cc/people/patrick-forde/>, <https://onco.cc/people/lu-shun/>, <https://onco.cc/people/enriqueta-felip/>, <https://onco.cc/people/julie-brahmer/>, <https://onco.cc/people/everett-vokes/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-immunotherapy-response/>, <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-dormancy-mrd/> ;
  onco:journals <https://onco.cc/journals/nejm/> .